Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Alzinova AB (78D) Stock Price & Analysis

0 Followers

78D Stock Chart & Stats

€0.02-€0.00(-15.79%)
At close: 5:30 PM GMT+1
€0.05€0.075€0.1€0.125Jul 13Jul 16Aug 12Sep 14Sep 24Oct 5
Day’s Range
EUR 0.02 - EUR 0.02
52-Week Range
EUR 0.01 - EUR 0.14
Previous Close
EUR 0.02
Volume
N/A
Average Volume (3M)
1,721
Market Cap
EUR 9.65M
Enterprise Value
EUR 66.43M
Total Cash (Recent Filing)
EUR 13.31M
Total Debt (Recent Filing)
EUR 800.00K
Price to Earnings (P/E)
―
Beta
1.64
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Minimal debt materially reduces financial pressure and leaves the company less exposed to interest costs or refinancing needs. This balance-sheet flexibility can help Alzinova continue funding research and respond to operating setbacks without excessive creditor constraints.

Equity Funding Capacity

The larger equity base provides a stronger capital cushion for a development-stage biotechnology company with continuing research requirements. It supports near-term financial flexibility and may allow Alzinova to advance its programs while limiting reliance on debt financing.

Focused Alzheimer’s Platform

A focused immunotherapy platform gives Alzinova a clear strategic direction within Alzheimer’s disease research rather than a broad, diffuse pipeline. Advancing candidates through clinical development creates potential for future out-licensing or commercialization if efficacy is demonstrated.

Bears Say

Persistent Operating Losses

Deep operating and net losses show that the business remains well below breakeven and is not currently converting its activities into sustainable earnings. Continued deficits can constrain strategic choices and increase the capital required to reach commercial development milestones.

Ongoing Cash Burn

Persistent negative operating and free cash flow indicates that Alzinova cannot currently fund operations and investment from internally generated cash. The deterioration in free cash flow increases the likelihood that additional external funding will be needed to sustain development.

Unstable Revenue Base

A small and volatile revenue base provides limited evidence of recurring commercial traction and makes future funding needs more dependent on pipeline progress. Revenue inconsistency also reduces visibility into the company’s ability to support development costs through operating income.

78D FAQ

What was Alzinova AB’s price range in the past 12 months?
Alzinova AB lowest stock price was €0.01 and its highest was €0.14 in the past 12 months.
What is Alzinova AB’s market cap?
Alzinova AB’s market cap is €9.65M.
When is Alzinova AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alzinova AB’s earnings last quarter?
Alzinova AB released its earnings results on Aug 20, 2026. The company reported -€0.003 earnings per share for the quarter.
Is Alzinova AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Alzinova AB pay dividends?
Alzinova AB does not currently pay dividends.
What is Alzinova AB’s EPS estimate?
Alzinova AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alzinova AB have?
Alzinova AB has 316,059,420 shares outstanding.
What happened to Alzinova AB’s price movement after its last earnings report?
Alzinova AB reported an EPS of -€0.003 in its last earnings report. Following the earnings report the stock price went down -3.125%.
Which hedge fund is a major shareholder of Alzinova AB?
Currently, no hedge funds are holding shares in DE:78D
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology